Company Overview of Nura Inc.
Nura, Inc., a development stage biotechnology company, engages in the development and discovery of therapeutics for behavioral disorders and neurodegenerative diseases. The company focuses on behavioral and neurodegenerative diseases with particular emphasis on G Protein-coupled receptor (GPCR) and phosphodiesterase (PDE) targets expressed in the brain. Its programs include schizophrenia, pain, and attention-deficit hyperactivity disorder. The company was founded in 2003 and is based in Seattle, Washington. As of September 7, 2006, Nura, Inc. operates as a subsidiary of Omeros Corporation.
1124 Columbia Street
Seattle, WA 98104
Founded in 2003
Key Executives for Nura Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Nura Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.